Incyte Corp/ US45337C1027 /

9/25/2023 9:59:59 PM	Chg. +0.69	Volume	Bid-	Ask-	Market Capitalization	Dividend Y.	P/E Ratio
58.77USD	+1.19%	106,708 Turnover: 6.23 mill.	-Bid Size: -	-Ask Size: -	13.17 bill.USD	-	38.40

TeleTrader 9/18 Wall Street opens mostly lower, Fed anticipation builds up

TeleTrader 2/7 Wall Street back to losses, Dow slides 200 points

TeleTrader 2/7 US markets lower amid economic data, Fed's Powell

GlobeNewswire 3/23/2022 RECELL® System Vitiligo Clinical Trial Protocol to be Presented at the Global Vitiligo Foundation An...

GlobeNewswire 3/14/2022 STRATA Skin Sciences Names John Bagdasarian as Vice President of Professional Relations

GlobeNewswire 3/1/2022 Actuate Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of Elraglusib Plus R...

GlobeNewswire 2/28/2022 Merus Announces Financial Results for the Fourth Quarter and Full Year 2021 and Provides Business Up...

GlobeNewswire 2/24/2022 MacroGenics Provides Update on Corporate Progress and 2021 Financial Results

GlobeNewswire 1/25/2022 Merus Appoints Shannon Campbell as Chief Commercial Officer and Regains Worldwide Rights to MCLA-145

GlobeNewswire 1/10/2022 Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agre...

GlobeNewswire 12/15/2021 AVITA Medical Completes Enrollment in Pivotal Trial Evaluating the RECELL® System for Repigmentation...

GlobeNewswire 12/11/2021 Annual Changes to the Nasdaq-100 Index®

GlobeNewswire 12/6/2021 Merus Presents Clinical Data on MCLA-145 at the ESMO Immuno-Oncology Congress 2021

GlobeNewswire 12/2/2021 Merus Announces Poster Presentation on Clinical Data on MCLA-145 at the ESMO Immuno-Oncology Congres...

GlobeNewswire 11/12/2021 Prelude Therapeutics Announces Third Quarter 2021 Financial Results and Operations Update

GlobeNewswire 11/10/2021 Ikena Oncology Reports Third Quarter 2021 Financial Results and Corporate Update

GlobeNewswire 11/9/2021 Calithera Biosciences Reports Third Quarter 2021 Financial Results and Recent Highlights

GlobeNewswire 11/2/2021 Merus Announces Regulatory Update on Zenocutuzumab, Financial Results for the Third Quarter and Prov...

GlobeNewswire 11/2/2021 MacroGenics Provides Update on Corporate Progress and Third Quarter 2021 Financial Results

TeleTrader 11/2/2021 US opens mixed as traders brace for Fed's meeting

GlobeNewswire 10/5/2021 LEVAR BURTON SELECTED AS 2022 TOURNAMENT OF ROSES® GRAND MARSHAL

GlobeNewswire 10/5/2021 October is Breast Cancer Awareness Month – BriaCell is Advancing the Fight with its Immunotherapy

GlobeNewswire 9/16/2021 MacroGenics Announces Clinical Results from Cohort A Part 1 of Phase 2/3 MAHOGANY Study of Margetuxi...

GlobeNewswire 9/1/2021 Brickell Biotech Expands Leadership Team, Appointing Dr. Monica Luchi as Chief Medical Officer

GlobeNewswire 8/26/2021 Bolt Biotherapeutics and Innovent Biologics Announce Collaboration to Develop Three New Oncology Bol...